Scandinavian Biopharma is present at Nordic Life Science Days
The Nordic region’s largest partnering conference for the global life science industry, Nordic Life Science Days (NLSD), is currently ongoing. NLSD attracts leading decision makers from biotech, pharma and MedTech as well as finance, research, policy and regulatory authorities. The event showcases a mixture of hot life science topics. On the agenda there is topical super sessions, seminars and company presentations.
Today’s Super session “Novel vaccine technologies and their impact on healthcare” deals with the rapid development of novel vaccine technologies, regulatory aspects and promises for new therapeutic vaccines to cure diseases in non-traditional therapeutic areas. Our CSO Nils Carlin will participate in the panel discussion and share his insights, thoughts and expertise regarding new techniques for vaccine development and oral vaccines.
Nils Carlin, CSO at Scandinavian Biopharma
